Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Rong

Showing results (331-340 of 482) with videos related to

Pageof 49
Sort By:
Chinese Medical Journal|April 12, 2012
Allo-hematopoietic stem cell transplantation is a potential treatment for a patient with a combined disorder of hereditary spherocytosisXiao-hui Zhang, Hai-xia Fu, Lan-ping Xu, et al.
Bone Marrow Transplantation|December 7, 2018
Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patientsWei Sun, Xiao-Dong Mo, Xiao-Hui Zhang, et al.
International Journal of Cancer|August 21, 2014
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groupsXiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Annals of Hematology|January 8, 2021
Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblingsYan-Ru Ma, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Frontiers in Immunology|September 20, 2021
The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell TransplantationMeng-Ge Gao, Yan Hong, Xiang-Yu Zhao, et al.
Cell Transplantation|June 4, 2024
Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell TransplantationXin-Ya Jiang, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 29, 2018
Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell TransplantationWen-Jing Yu, Xiao-Dong Mo, Xiao-Hui Zhang, et al.
Zhonghua Yi Xue Za Zhi|February 12, 2008
[Candida species distribution in the patients with high risk of deep fungal infections and relevant risk factors: a prospective cohort study]Jin Yu, Min Zhang, Jian-Lei Wang, et al.
Annals of Hematology|July 9, 2015
The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantationYu-Qian Sun, Gan-Lin He, Ying-Jun Chang, et al.
The American Journal of Medicine|February 21, 2012
Hypertensive disorders in pregnancy and subsequent diabetes mellitus: a retrospective cohort studyI-Kuan Wang, I-Ju Tsai, Pei-Chun Chen, et al.
Pageof 49

Showing results (331-340 of 482) with videos related to

Sort By:
Pageof 49
Chinese Medical Journal|April 12, 2012
Allo-hematopoietic stem cell transplantation is a potential treatment for a patient with a combined disorder of hereditary spherocytosisXiao-hui Zhang, Hai-xia Fu, Lan-ping Xu, et al.
Bone Marrow Transplantation|December 7, 2018
Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patientsWei Sun, Xiao-Dong Mo, Xiao-Hui Zhang, et al.
International Journal of Cancer|August 21, 2014
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groupsXiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Annals of Hematology|January 8, 2021
Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblingsYan-Ru Ma, Lan-Ping Xu, Xiao-Hui Zhang, et al.
Frontiers in Immunology|September 20, 2021
The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell TransplantationMeng-Ge Gao, Yan Hong, Xiang-Yu Zhao, et al.
Cell Transplantation|June 4, 2024
Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell TransplantationXin-Ya Jiang, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 29, 2018
Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell TransplantationWen-Jing Yu, Xiao-Dong Mo, Xiao-Hui Zhang, et al.
Zhonghua Yi Xue Za Zhi|February 12, 2008
[Candida species distribution in the patients with high risk of deep fungal infections and relevant risk factors: a prospective cohort study]Jin Yu, Min Zhang, Jian-Lei Wang, et al.
Annals of Hematology|July 9, 2015
The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantationYu-Qian Sun, Gan-Lin He, Ying-Jun Chang, et al.
The American Journal of Medicine|February 21, 2012
Hypertensive disorders in pregnancy and subsequent diabetes mellitus: a retrospective cohort studyI-Kuan Wang, I-Ju Tsai, Pei-Chun Chen, et al.
Pageof 49